Department of Biological Science, Kongju National University, Gongju, South Korea.
J Peripher Nerv Syst. 2012 Dec;17(4):418-21. doi: 10.1111/j.1529-8027.2012.00442.x.
Glycyl-tRNA synthetase (GARS), which encodes the enzyme responsible for charging tRNA(Gly) with glycine in both the cytoplasm and mitochondria, is implicated to Charcot-Marie-Tooth disease 2D (CMT2D) and distal hereditary motor neuropathy type V (dHMN-V). We performed whole exome sequencing (WES) to identify the genetic defects in the two dHMN families. WES revealed several decades of non-synonymous variants in the CMT and aminoacyl-tRNA synthetase genes. The subsequent capillary sequencing for family members and controls revealed two novel causative mutations, c.598G>A (D200N) and c.794C>T (S265F), in the GARS gene in each dHMN family. Both mutations were cosegregated with affected individuals in each family, and were not found in the 200 controls. The mutation sites were well conserved between the different species and in silico analysis predicted that both mutations may affect protein function. Therefore, we believe that these two novel GARS mutations are the underlying causes of the dHMN phenotype.
甘氨酰-tRNA 合成酶(GARS)在细胞质和线粒体中负责将甘氨酸加载到 tRNA(Gly)上,它与 Charcot-Marie-Tooth 病 2D(CMT2D)和远端遗传性运动神经病 5 型(dHMN-V)有关。我们进行了全外显子组测序(WES),以鉴定这两个 dHMN 家族的遗传缺陷。WES 发现了 CMT 和氨酰-tRNA 合成酶基因中的数十种非同义变异。随后对家族成员和对照者进行毛细管测序,发现每个 dHMN 家族的 GARS 基因中存在两个新的致病突变,c.598G>A(D200N)和 c.794C>T(S265F)。这两个突变在每个家族的受影响个体中与疾病共分离,并且在 200 个对照中未发现。突变位点在不同物种之间高度保守,并且计算机分析预测这两个突变可能影响蛋白质功能。因此,我们认为这两个新的 GARS 突变是 dHMN 表型的潜在原因。